Effect of carotenoids dietary supplementation on macular function in diabetic patients
- PMID: 29046877
- PMCID: PMC5641400
- DOI: 10.1186/s40662-017-0088-4
Effect of carotenoids dietary supplementation on macular function in diabetic patients
Abstract
Background: Diabetic retinopathy is a major cause of visual impairment and blindness among working-age people worldwide. The aim of our study was to investigate the effects of a carotenoid supplementation on retinal thickness and macular function of patients with diabetes using optical coherence tomography (OCT) and multifocal electroretinography (mfERG).
Methods: A retrospective study of one hundred and twenty eyes of sixty patients age between 40 and 60 years with non-insulin dependent type 2 diabetes mellitus without diabetic retinopathy who underwent OCT and mfERG and took vitamin supplements for a period of two years. Patients received a carotenoid supplement containing lutein (10 mg), zeaxanthin (2 mg) and meso-zeaxanthin (10 mg) once a day for two years. The thickness of the fovea was evaluated using OCT and the macular function was tested by mfERG.
Results: OCT showed an increase in the central foveal thickness and mfERG revealed increased retinal response density within the central 13° surrounding the fovea (rings 1 to 3) at two years after the onset of carotenoids supplement intake.
Conclusion: The use of carotenoid supplements may be of benefit for improving visual function of type 2 diabetes patients. However, further study is needed to assess the treatment's long-term efficacy.
Keywords: Carotenoids; Diabetes mellitus; Multifocal electroretinography; Optical coherence tomography; Visual function.
Conflict of interest statement
Ethics approval and consent to participate
Approved by the institutional review board of “G. Gennimatas” General Hospital, Athens, Greece (ID 30726/83).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Figures
References
-
- Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417–1436. doi: 10.1001/archopht.119.10.1417. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
